Skip to main content
SpringerLink
Log in

Virale Kanzerogenese von Kopf-Hals-Tumoren

  • Schwerpunkt: Orale Pathologie/Pathologie der Speicheldrüsen
  • Published:
Der Pathologe Aims and scope Submit manuscript

Zusammenfassung

Infektiöse Erreger sind für etwa 15% aller Krebserkrankungen weltweit verantwortlich. Humane Papillomviren (HPV) werden häufig in oralen Karzinomen, v. a. der Tonsillen, gefunden. Für eine Gruppe dieser Tumoren konnte eine klare virale Ätiologie nachgewiesen werden: Hochrisiko-Papillomviren kommen in allen Tumorzellen vor, die viralen Onkogene E6 und E7 werden konstant exprimiert und führen zu der diagnostisch richtungsweisenden Überexpression des zellulären Proteins p16INK4a, einem cyclinabhängigen Kinaseinhibitor. Nikotin- oder Alkoholabusus—typisch für die nicht virusassoziierten Karzinome—liegt bei den Patienten nur selten vor.

Epstein-Barr-Viren sind für lymphoproliferative Erkrankungen verantwortlich, aber auch für das Nasopharynx-Karzinom (NPC). In Ostasien ist das NPC nicht selten, und das Screening auf virale Marker hat einen hohen klinischen Stellenwert erlangt.

In dieser Übersicht werden die grundlegenden Mechanismen der molekularen Pathogenese von HPV- und EBV-assoziierten Malignomen dargestellt und klinische Konsequenzen der vorliegenden Ergebnisse für die Diagnostik diskutiert.

Abstract

Approximately 15% of malignant diseases are caused by infectious agents. Human papilloma viruses (HPV) can be frequently found in oral carcinomas, especially tonsillar cancer. A group of HPV-infected tumors shows clear signs for a virally induced transformation process: high-risk HPVs can be detected in all tumor cells, the viral oncogenes E6 and E7 are constantly expressed and lead to upregulation of cellular p16INK4a, a cyclin-dependent kinase inhibitor. The patients frequently lack typical risk factors associated with head and neck cancers such as drinking and smoking.

Epstein-Barr viruses (EBV) are associated with lymphoproliferative disorders and cause nasopharyngeal carcinoma (NPC). NPC has a high incidence in some East Asian countries.

In this review, the molecular pathogenesis of HPV- and EBV-associated malignancies are described and the clinical relevance of the presented findings is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Aaltonen LM, Rihkanen H, Vaheri A (2002) Human papillomavirus in larynx. Laryngoscope 112: 700–707

    Article  PubMed  Google Scholar 

  2. Bibbo M, Klump WJ, DeCecco J, Kovatich AJ (2002) Procedure for immunocytochemical detection of P16INK4a antigen in thin-layer, liquid-based specimens. Acta Cytol 46: 25–29

    PubMed  Google Scholar 

  3. Bouda M, Gorgoulis VG, Kastrinakis NG et al. (2000) „High risk“ HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol 13: 644–653

    CAS  PubMed  Google Scholar 

  4. Chan KH, Gu YL, Ng F et al. (2003) EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Int J Cancer 105: 706–709

    Article  CAS  PubMed  Google Scholar 

  5. Cheng WM, Chan KH, Chen HL et al. (2002) Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum. Int J Cancer 97: 489–492

    Article  CAS  PubMed  Google Scholar 

  6. Duensing S, Munger K (2001) Centrosome abnormalities, genomic instability and carcinogenic progression. Biochim Biophys Acta 1471: M81-M88

    CAS  PubMed  Google Scholar 

  7. Galloway DA (2003) Papillomavirus vaccines in clinical trials. Lancet Infect Dis 3: 469–475

    Article  CAS  PubMed  Google Scholar 

  8. Giovannelli L, Campisi G, Lama A et al. (2002) Human papillomavirus DNA in oral mucosal lesions. J Infect Dis 185: 833–836

    Article  CAS  PubMed  Google Scholar 

  9. Hohenberger P, Gretschel S (2003) Gastric cancer. Lancet 362: 305–315

    Article  PubMed  Google Scholar 

  10. Hubbard RA (2003) Human papillomavirus testing methods. Arch Pathol Lab Med 127: 940–945

    CAS  PubMed  Google Scholar 

  11. Klaes R, Woerner SM, Ridder R et al. (1999) Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 59: 6132–6136

    CAS  PubMed  Google Scholar 

  12. Klaes R, Friedrich T, Spitkovsky D et al. (2001) Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92: 276–284

    CAS  PubMed  Google Scholar 

  13. Klaes R, Benner A, Friedrich T et al. (2002) p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 26: 1389–1399

    Article  PubMed  Google Scholar 

  14. Klussmann JP, Gultekin E, Weissenborn SJ et al. (2003) Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 162: 747–753

    CAS  PubMed  Google Scholar 

  15. Lo YM, Chan LY, Chan AT et al. (1999) Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res 59: 5452–5455

    CAS  PubMed  Google Scholar 

  16. Loren AW, Porter DL, Stadtmauer EA, Tsai DE (2003) Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant 31: 145–155

    Article  CAS  PubMed  Google Scholar 

  17. Luft F, Klaes R, Nees M et al. (2001) Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer 92: 9–17

    Article  CAS  PubMed  Google Scholar 

  18. Macsween KF, Crawford DH (2003) Epstein-Barr virus-recent advances. Lancet Infect Dis 3: 131–140

    Article  PubMed  Google Scholar 

  19. Mantovani F, Banks L (2001) The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20: 7874–7887

    Article  CAS  PubMed  Google Scholar 

  20. McKaig RG, Baric RS, Olshan AF (1998) Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 20: 250–265

    CAS  PubMed  Google Scholar 

  21. Mellin H, Dahlgren L, Munck-Wikland E et al. (2002) Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 102: 152–158

    Article  CAS  PubMed  Google Scholar 

  22. Moody CA, Scott RS, Su T, Sixbey JW (2003) Length of Epstein-Barr virus termini as a determinant of epithelial cell clonal emergence. J Virol 77: 8555–8561

    Article  CAS  PubMed  Google Scholar 

  23. Munger K, Basile JR, Duensing S et al. (2001) Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20: 7888–7898

    Article  CAS  PubMed  Google Scholar 

  24. Murphy N, Ring M, Killalea AG et al. (2003) p16INK4aas a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 56: 56–63

    Article  CAS  PubMed  Google Scholar 

  25. Mutiu A, Alexiu I, Chivu M et al. (2001) Detection of human papillomavirus gene sequences in cell lines derived from laryngeal tumors. J Cell Mol Med 5: 49–59

    CAS  PubMed  Google Scholar 

  26. Negri G, Egarter-Vigl E, Kasal A et al. (2003) p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol 27: 187–193

    Article  PubMed  Google Scholar 

  27. Ohga S, Nomura A, Takada H, Hara T (2002) Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol 44: 203–215

    Article  PubMed  Google Scholar 

  28. Raab-Traub N (2002) Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 12: 431–441

    Article  CAS  PubMed  Google Scholar 

  29. Rickinson A (2002) Epstein-Barr virus. Virus Res 82: 109–113

    Article  CAS  PubMed  Google Scholar 

  30. Ritchie JM, Smith EM, Summersgill KF et al. (2003) Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 104: 336–344

    Article  CAS  PubMed  Google Scholar 

  31. Rosin MP, Anwar WA, Ward AJ (1994) Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Res 54: 1929s–1933s

    CAS  PubMed  Google Scholar 

  32. Strome SE, Savva A, Brissett AE et al. (2002) Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res 8: 1093–1100

    CAS  PubMed  Google Scholar 

  33. Sugiyama M, Bhawal UK, Dohmen T et al. (2003) Detection of human papillomavirus-16 and HPV-18 DNA in normal, dysplastic, and malignant oral epithelium. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95: 594–600

    Article  PubMed  Google Scholar 

  34. Takada K (2000) Epstein-Barr virus and gastric carcinoma. Mol Pathol 53: 255–261

    Article  CAS  PubMed  Google Scholar 

  35. Takada K (2001) Role of Epstein-Barr virus in Burkitt’s lymphoma. Curr Top Microbiol Immunol 258: 141–151

    CAS  PubMed  Google Scholar 

  36. Tsuchiya S (2002) Diagnosis of Epstein-Barr virus-associated diseases. Crit Rev Oncol Hematol 44: 227–238

    Article  PubMed  Google Scholar 

  37. Wentzensen N, Ridder R, Klaes R et al. (2002) Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions. Oncogene 21: 419–426

    Article  CAS  PubMed  Google Scholar 

  38. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX (2002) Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 21: 1510–1517

    Article  CAS  PubMed  Google Scholar 

  39. Young LS, Murray PG (2003) Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22: 5108–5121

    Article  CAS  PubMed  Google Scholar 

  40. zur Hausen H (1999) Viruses in human cancers. Eur J Cancer 35: 1878–1885

    PubMed  Google Scholar 

  41. zur Hausen H (2000) Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92: 690–698

    Article  PubMed  Google Scholar 

  42. zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342–350

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt:

Der korrespondierende Autor weist auf eine Verbindung mit folgender Firma/Firmen hin: Der Autor ist Gründer, Anteilseigner, Berater und AR-Mitglied der Firma mtm-laborationes AG, die einen p16INK4a-Antikörper vertreibt.

Author information

Authors and Affiliations

  1. Abteilung für Molekulare Pathologie, Pathologisches Institut der Universität Heidelberg

    N. Wentzensen &  M. von Knebel Doeberitz

  2. Abteilung für Molekulare Pathologie, Pathologisches Institut der Universität Heidelberg, Im Neuenheimer Feld 220, 69120 , Heidelberg

    M. von Knebel Doeberitz

Authors
  1. N. Wentzensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. von Knebel Doeberitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. von Knebel Doeberitz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wentzensen, N., von Knebel Doeberitz, M. Virale Kanzerogenese von Kopf-Hals-Tumoren. Pathologe 25, 21–30 (2004). https://doi.org/10.1007/s00292-003-0669-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00292-003-0669-y

Schlüsselwörter

Keywords

Search

Navigation